In an early report from an ongoing, randomized clinical trial, researchers from UCSF have shown that the addition of the immune stimulator interleukin-2 (IL-2) to highly active antiretroviral therapy (HAART) improves immune function in patients who have been recently infected with HIV.

A study by the San Francisco Department of Public Health, conducted at the San Francisco County Jail, has found that anonymous HIV screening of jail inmates offers an opportunity to track the epidemic in at-risk groups...

The right of University of California scientists to carry out tobacco smoking research and anti-smoking advocacy was affirmed by the U.S. Court of Appeals in Sacramento Thursday (July 6).

Diagnosing Alzheimer's disease may become easier with the help of imaging studies from the San Francisco Veteran's Affairs Medical Center, which is affiliated with UC San Francisco.

A University of California, San Francisco program that uses certified nurse midwives and nurse practitioners as primary care givers has significantly reduced transmission of HIV from mother to child...

A new study headed by a University of California, San Francisco AIDS researcher has determined that providing the female condom to women who are commercial sex workers in rural South Africa is a highly cost-effective means of preventing HIV transmission...

Results from two studies proving the efficacy and cost-effectiveness of providing voluntary counseling and testing for HIV-1 in developing countries are reported in the new issue (July 8) of the British medical journal The Lancet.

UC San Francisco researchers have discovered a region in the telomerase enzyme that they say could prove to be a target for killing cancer cells and regenerating damaged cells, and could also lead to a possible target for attacking HIV.